Phase 2 Readout~quarter
Phase 2 Readout: img-007
- Company
- ImageneBio, Inc. (IMA)
- Drug
- img-007
- Indication
- atopic dermatitis
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Get real-time alerts, AI-powered analysis, and full catalyst coverage.